Merit Medical Systems, Inc. (MMSI)
NASDAQ: MMSI · Real-Time Price · USD
94.61
-0.06 (-0.06%)
Apr 25, 2025, 4:00 PM EDT - Market closed
Merit Medical Systems Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Revenue | 1,388 | 1,357 | 1,257 | 1,151 | 1,075 | 963.88 | Upgrade
|
| Revenue Growth (YoY) | 8.19% | 7.89% | 9.24% | 7.09% | 11.50% | -3.11% | Upgrade
|
| Cost of Revenue | 724.72 | 713.18 | 673.49 | 631.88 | 589.42 | 562.7 | Upgrade
|
| Gross Profit | 663.64 | 643.33 | 583.87 | 519.1 | 485.33 | 401.18 | Upgrade
|
| Selling, General & Admin | 409.69 | 396.63 | 370.98 | 335.33 | 329.69 | 297.72 | Upgrade
|
| Research & Development | 88.46 | 87.47 | 82.73 | 75.51 | 71.25 | 57.54 | Upgrade
|
| Operating Expenses | 498.15 | 484.1 | 453.7 | 410.84 | 400.94 | 355.26 | Upgrade
|
| Operating Income | 165.49 | 159.24 | 130.17 | 108.26 | 84.4 | 45.92 | Upgrade
|
| Interest Expense | -29.74 | -31.22 | -15.51 | -6.34 | -5.26 | -9.99 | Upgrade
|
| Interest & Investment Income | 22.74 | 26.23 | 2.46 | 0.44 | 0.77 | 0.6 | Upgrade
|
| Currency Exchange Gain (Loss) | 0.92 | 1.96 | 2 | 1.42 | -1.6 | -2.19 | Upgrade
|
| Other Non Operating Income (Expenses) | -1.12 | -2.67 | -0.8 | -0.45 | -0.91 | -0.61 | Upgrade
|
| EBT Excluding Unusual Items | 158.29 | 153.54 | 118.31 | 103.33 | 77.4 | 33.73 | Upgrade
|
| Merger & Restructuring Charges | -3.1 | -3.1 | -2.7 | -7.2 | -2.7 | - | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | -0.27 | -0.5 | - | -6 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | - | - | - | 0.52 | Upgrade
|
| Asset Writedown | - | - | - | -1.72 | -1.58 | -30.5 | Upgrade
|
| Legal Settlements | - | - | - | - | -10.04 | -18.68 | Upgrade
|
| Other Unusual Items | -1.58 | -0.44 | -1.7 | -4.61 | -9.16 | 7.96 | Upgrade
|
| Pretax Income | 153.6 | 149.99 | 112.09 | 82.63 | 53.92 | -13.23 | Upgrade
|
| Income Tax Expense | 31.34 | 29.64 | 17.68 | 8.11 | 5.46 | -3.39 | Upgrade
|
| Net Income | 122.26 | 120.36 | 94.41 | 74.52 | 48.45 | -9.84 | Upgrade
|
| Net Income to Common | 122.26 | 120.36 | 94.41 | 74.52 | 48.45 | -9.84 | Upgrade
|
| Net Income Growth | 19.93% | 27.48% | 26.70% | 53.79% | - | - | Upgrade
|
| Shares Outstanding (Basic) | 58 | 58 | 58 | 57 | 56 | 55 | Upgrade
|
| Shares Outstanding (Diluted) | 60 | 59 | 58 | 58 | 57 | 55 | Upgrade
|
| Shares Change (YoY) | 2.72% | 1.73% | 1.19% | 0.54% | 3.47% | -1.42% | Upgrade
|
| EPS (Basic) | 2.09 | 2.07 | 1.64 | 1.31 | 0.86 | -0.18 | Upgrade
|
| EPS (Diluted) | 2.04 | 2.03 | 1.62 | 1.29 | 0.84 | -0.18 | Upgrade
|
| EPS Growth | 17.19% | 25.31% | 25.58% | 53.57% | - | - | Upgrade
|
| Free Cash Flow | 180.64 | 185.66 | 110.86 | 69.26 | 119.29 | 119.28 | Upgrade
|
| Free Cash Flow Per Share | 3.01 | 3.13 | 1.90 | 1.20 | 2.08 | 2.15 | Upgrade
|
| Gross Margin | 47.80% | 47.42% | 46.44% | 45.10% | 45.16% | 41.62% | Upgrade
|
| Operating Margin | 11.92% | 11.74% | 10.35% | 9.41% | 7.85% | 4.76% | Upgrade
|
| Profit Margin | 8.81% | 8.87% | 7.51% | 6.47% | 4.51% | -1.02% | Upgrade
|
| Free Cash Flow Margin | 13.01% | 13.69% | 8.82% | 6.02% | 11.10% | 12.38% | Upgrade
|
| EBITDA | 273.89 | 261.95 | 220.15 | 190.07 | 168.46 | 139.99 | Upgrade
|
| EBITDA Margin | 19.73% | 19.31% | 17.51% | 16.51% | 15.68% | 14.52% | Upgrade
|
| D&A For EBITDA | 108.4 | 102.71 | 89.99 | 81.8 | 84.07 | 94.07 | Upgrade
|
| EBIT | 165.49 | 159.24 | 130.17 | 108.26 | 84.4 | 45.92 | Upgrade
|
| EBIT Margin | 11.92% | 11.74% | 10.35% | 9.41% | 7.85% | 4.76% | Upgrade
|
| Effective Tax Rate | 20.40% | 19.76% | 15.77% | 9.82% | 10.13% | - | Upgrade
|
Updated Apr 24, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.